Research Management Group (RMG)

Dr. Ralph and Marian Falk Medical Research Trust Awards Program
Catalyst Award

***$300,000 Limited program for Stanford faculty with PI eligibility. Stanford has been invited to submit two applications for the following award. Therefore, a university-wide internal selection process is required. This program is designed to support high-risk, high-reward projects that address critical scientific and therapeutic roadblocks.

The target of the Falk Catalyst’s funding are projects at the intersection of technology and clinical science, intended to move from insights gained from basic science towards creating solutions, techniques and tools that can be transferred to clinical practice in the near term. Please see eligibility, research focus, catalyst award description.


# of applicants permitted
: 2 (see the internal submission guidelines below)




Timeline:
Internal selection process deadline: Tuesday, June 5, 2018, 5 p.m.(see internal submission guidelines below)
For applicants selected:
Institutional representative (RPM/RMG or OSR): July  17, 2018
Full proposal deadline: July 24, 2018

 

Sponsor website: https://hria.org/tmf/falkcap/
Download the RFP and application forms from the above webpage.
Download a PDF file of the FAQs >>
Download a PDF file of the Catalyst Award recipients >> (Stanford recipients: 1 in 2017, 1 in 2016, 1 in 2015)
See Stanford eligiblity clarification below.



Amount of funding:
One-year awards of up to $300,000 (inclusive of 10% indirect costs)
Grant period: November 30, 2018 - November 29, 2019
The number of Catalyst Awards available will be determined by the Trustee each year, depending on the availability of funds and the merit of the applications received.



Eligibility

Invited Institutions may nominate up to two individual investigators who meeting the following eligibility requirements to submit an application:



Purpose:
The Catalyst Awards provide an opportunity to conduct preliminary work on high-risk, high-reward research addressing a wide variety of clinical disease areas. The target of the Falk Catalyst’s funding are projects at the intersection of technology and clinical science, intended to move from insights gained from basic science towards creating solutions, techniques and tools that can be transferred to clinical practice in the near term. The Catalyst Awards are a stepping stone to eligibility for the Falk Transformational Awards Program. In order to be funded Catalyst research projects must describe specific milestones and benchmarks that if successfully met, would then enable recipients to apply for additional funding through the two-year Transformational Awards program.


The Dr. Ralph and Marian Falk Medical Research Trust, U. S. Trust, Bank of America N.A., Trustee, works with The Medical Foundation, a division of Health Resources in Action (HRiA), to select the most qualified applicants. HRiA is a nonprofit organization in Boston, MA that advances public health and medical research through the creation and oversight of biomedical research grant programs.


The Catalyst Awards:



Research Focus (required):
This program is designed to support high-risk, high-reward projects that address critical scientific and therapeutic roadblocks. If successful, these projects will open new avenues for treating and curing disease. The Program has three principal areas of focus:



Collaborations:

The Trust encourages the use of collaborations between industry, government, academic and disease advocacy organizations. Awards will be made via a contract awarded to a single institution responsible for satisfying the administration, performance and reporting requirement of the contract. Other collaborating organizations, both non-profit and for-profit, may be sub-contracted to the lead institution and must designate a lead principal investigator who is responsible for performance under the contract. In support of this collaborative approach, the Catalyst Program may provide funding to investigators for:

 


Review Criteria:

 


INTERNAL SUBMISSION GUIDELINES:

By Tuesday, June 5, 2018, 5 p.m., please submit one PDF file containing the following in the order listed below to:

Jeanne Heschele
Research Management Group
jheschele@stanford.edu
650-245-2351

File name: Last name_Falk_2018.pdf

Institutional representatives: not applicable. You do not have to submit your internal proposals to RMG or OSR for their approval. You can submit your internal proposals directly to Jeanne.

1) Title Page
Dr. Ralph and Marian Falk Medical Research Trust Awards Program Catalyst Awards Program
Project title:
Principle area of focus (select one of the 3 required topics):
-Identification of biological markers of disease activity and progression,
-Identification of targets for therapeutic interventions, and
-Development of therapeutic agents that will disrupt, arrest, or prevent the disease process.
PI: name, title, department, address, phone and email address
Co-PI (if applicable): name, title, department, address, phone and email address
Co-investigators name, title, department, address, phone and email address

2) Research Project description: up to 4 pages
Include your specific aims, methods, milestones and benchmarks (refer to FAQs, research focus)
References and illustrations are not included in the page total.
Format: single-spaced, one-sided, Arial or Helvetica font size 11 or larger, 1/2 margins

4) Biosketches- for the PI , Co-PI (if applicable), and Co-investigators-- (including current and pending other support-sponsor name, term, amount of funding)


Selection process
Your proposals will be reviewed by Dr. Peter Sarnow and the School of Medicine Awards committee. That committee will select the two applicants to represent the university.


 

 

Footer Links: